NIH-funded research R21 grant

Detecting aging cells in the pancreas

Official title: Specific senescence detection in pancreatic islets

Funded at University of Florida · NIH-10648322 · Data updated 2026-11-12

This study is looking at how aging cells in the pancreas might play a role in type 2 diabetes, especially in older adults, and aims to create a special tool to spot these cells so we can learn more about the disease and find better ways to treat it.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startSeptember 15, 2023
Project endSeptember 14, 2025
Funding year2023
Award (this year)$419,375
NIH project number1R21AG081869-01
Project IDNIH-10648322 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults, especially those diagnosed with type 2 diabetes or at risk of developing it.

Less likely to help

Patients who are younger and do not have diabetes or related metabolic disorders may not benefit from this research.

What this research studies

This research focuses on understanding how aging cells in the pancreas contribute to type 2 diabetes, a condition that affects many older adults. The team aims to develop a new molecular probe that can identify senescent (aging) cells in pancreatic islets in real-time. By studying these cells in both isolated samples and live mouse models of diabetes, the researchers hope to uncover important insights into the progression of the disease and the role of cellular aging. This could lead to better-targeted therapies for managing diabetes.

Why it matters

Potential benefit: If successful, this research could lead to improved methods for diagnosing and treating type 2 diabetes, particularly in older patients.

How similar studies have gone: Previous research has shown promising results in targeting cellular senescence for various age-related diseases, suggesting that this approach could be effective for diabetes as well.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Cui, Lina — University of Florida
  • Study coordinator: Cui, Lina

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.